Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus

Rheumatology

Volumn 45, Issue 6, 2006, Pages 711-717

  Hur, J W ^a   Sung, Y K ^a   Shin, H D ^b   Park, B L ^b   Cheong, H S ^b   Bae, S C ^a  

^a Hanyang Institute of Bioscience and Biotechnology   (South Korea)

^b SNP Genetics Inc   (South Korea)

Author keywords

Poly(ADP ribose) polymerases; Single nucleotide polymorphism; Systemic lupus erythematosus

Indexed keywords

DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; DNA SEQUENCE; EXON; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ARTHRITIS; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33745595354     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei262     Document Type: Article

References (43)

1. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
2. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
3. Golan TD, Foltyn V, Roueff A. Increased susceptibility to in vitro ultraviolet B radiation in fibroblasts and lymphocytes cultured from systemic lupus erythematosus patients. Clin Immunol Immunopathol 1991;58:289-304.
4. Rosenstein BS, Rosenstein RB, Zamansky GB. Repair of DNA damage induced in systemic lupus erythematosus skin fibroblasts by simulated sunlight. J Invest Dermatol 1992;98:469-74.
5. Tsao BP, Cantor RM, Grossman JM et al. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest 1999;103:1135-40.
6. Auer B, Nagl U, Herzog H, Schneider R, Schweiger M. Human nuclear NAD+ ADP-ribosyltransferase (polymerizing): Organization of the gene. DNA 1989;8:575-80.
7. Oliver FJ, Menissier-de Murcia J, de Murcia G. Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 1999;64:1282-8.
8. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl) ation reactions in the regulation of nuclear functions. Biochem J 1999;342:249-68.
9. Sibley JT, Haug BL, Lee JS. Altered metabolism of poly(ADP-ribose) in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:1045-9.
10. Haug BL, Lee JS, Sibley JT. Altered poly(ADP-ribose) metabolism in family members of patients with systemic lupus erythematosus. J Rheumatol 1994;21:851-6.
11. Oei SL, Shi Y. Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl) ation and DNA repair. Biochem Biophys Res Commun 2001;284:450-4.
12. Criswell LA, Moser KL, Gaffney PM et al. PARP alleles and SLE: Failure to confirm association with disease susceptibility. J Clin Invest 2000;105:1501-2.
13. Delrieu O, Michel M, Frances C et al. Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum 1999;42:2194-7.
14. Boorboor P, Drescher BE, Hartung K et al. Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German Caucasians. J Rheumatol 2000;27: 2061.
15. Kono DH, Burlingame RW, Owens DG et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994; 91:10168-72.
16. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol 1995;154:2441-7.
17. Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998;19:287-98.
18. Jawaheer D, Seldin MF, Amos CI et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001;68:927-36.
19. Pascual M, Lopez-Nevot MA, Caliz R et al. A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis. Arthritis Rheum 2003;48:638-41.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
21. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
22. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-9.
23. Hedrick PW. Gametic disequilibrium measures: Proceed with caution. Genetics 1987;117:331-41.
24. Hedrick P, Kumar S. Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet 2001;9:969-72.
25. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
26. Kato N, Morita H, Sugiyama T et al. Evaluation of the poly(ADP-ribose) polymerase gene in human stroke. Atherosclerosis 2000; 148:345-52.
27. Cottet F, Blanche H, Verasdonck P et al. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: Lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity. J Mol Med 2000;78:431-40.
28. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998;95:14875-9.
29. Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95:14869-74.
30. Fougerousse F, Meloni R, Roudaut C, Beckmann JS. Dinucleotide repeat polymorphism at the human poly (ADP-ribose) polymerase gene (PPOL). Nucleic Acids Res 1992;20:1166.
31. Wang ZQ, Stingl L, Morrison C et al. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 1997;11:2347-58.
32. Masutani M, Suzuki H, Kamada N et al. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999;96:2301-4.
33. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998;273:33533-9.
34. Yu SW, Wang H, Poitras MF et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002;297:259-63.
35. Suzuki N, Mihara S, Sakane T. Development of pathogenic anti-DNA antibodies in patients with systemic lupus erythematosus. Faseb J 1997;11:1033-8.
36. Ravirajan CT, Rahman MA, Papadaki L et al. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis. Eur J Immunol 1998;28:339-50.
37. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994;1:219-29.
38. Mohan C, Alas E, Morel L, Yang P, Wakeland EK. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 1998;101:1362-72.
39. Waters ST, McDuffie M, Bagavant H et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004;199:255-64.
40. Decker P, Briand JP, de Murcia G, Pero RW, Isenberg DA, Muller S. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases. Arthritis Rheum 1998;41:918-26.
41. Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin Immunol Immunopathol 1995;77:349-57.
42. Decker P, Isenberg D, Muller S. Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J Biol Chem 2000;275:9043-6.
43. Karassa FB, Trikalinos TA, Ioannidis JP. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis. Kidney Int 2003;63: 1475-82.